Last reviewed · How we verify
NCT03819179
The Influence of Personal Care Products on the Skin Microbiome
NA trial testing Burt's Bees Serum in Microbiome in 30 participants. Completed in 6 February 2018.
6 February 2018
Quick facts
| Lead sponsor | University of California, Davis |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 30 |
| Start date | 1 December 2017 |
| Primary completion | 6 February 2018 |
| Estimated completion | 6 February 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Burt's Bees Serum
- Burt's Bees Serum with Biulin
- Burt's Bees Serum with Bonicell
- Burt's Bees Serum with Berenew Complex
- Burt's Bees Serum with Ecoskin
Conditions studied
- Microbiome — all drugs for Microbiome →
Sponsor
University of California, Davis
Who can join
Adults 20 to 45, female only, with Microbiome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate whether personal care products shift the skin microbiome bacteria and diversity after a week of daily use.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03819179
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Microbiome
Currently open trials in the same condition.
- NCT07501455 — Comparison of the Effects of Oral Hygiene Regimens on Clinical, Immunomodulatory, and Microbial Outcomes and Oral Tolera · NA · recruiting
- NCT07439718 — The Effects of an Oral Nutritional Intervention on the Small Intestine Microbiome · NA · recruiting
- NCT07209007 — Dynamics of Dysbiosis in the Skin and Gut Microbiome of Burn Patients · recruiting
- NCT06778083 — STI Prophylaxis and Emergence of Antimicrobial Resistance · recruiting
- NCT06606119 — The Role of Brain-Bone Marrow-Gut Interaction Following Major Trauma · recruiting
Other University of California, Davis trials
Trials by the same sponsor.
- NCT07024498 — Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment · NA · not yet recruiting
- NCT07322133 — Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE) · Phase 4 · recruiting
- NCT07384767 — Efficacy and Safety of Topical Timolol in Secondary Intention Surgical Wounds Healing · Phase 2 · not yet recruiting
- NCT07267494 — Image-Guided Herniorrhaphy Study · NA · not yet recruiting
- NCT04614714 — Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants · Phase 2, PHASE3 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03819179 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, Davis
- Last refreshed: 28 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03819179.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing